Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Life Sciences & Biomedicine Microbiology Science & Technology
Vancomycin-resistant enterococci (VRE) are a serious threat to human health, with few treatment options being available. New therapeutics are urgently needed to relieve the health and economic burdens presented by VRE. A potential target for new therapeutics is the VanRS two-component system, which regulates the expression of vancomycin resistance in VRE. VanS is a sensor histidine kinase that detects vancomycin and in turn activates VanR; VanR is a response regulator that, when activated, directs expression of vancomycin-resistance genes. This review of VanRS examines how the expression of vancomycin resistance is regulated, and provides an update on one of the field's most pressing questions: How does VanS sense vancomycin?
Regulation of Resistance in Vancomycin-Resistant Enterococci: The VanRS Two-Component System
Creators
Alexandra A. Guffey - Drexel University
Patrick J. Loll - Drexel University
Publication Details
Microorganisms (Basel), v 9(10), p2026
Publisher
Mdpi
Number of pages
26
Grant note
1R01AI148679 / NIH-NIAID; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)
Resource Type
Journal article
Language
English
Academic Unit
Biochemistry and Molecular Biology
Web of Science ID
WOS:000712851200001
Scopus ID
2-s2.0-85115805562
Other Identifier
991019170121504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: